Dogwood Therapeutics, Inc DWTX
1.36
(0.07)
(4.90%)
as of 25 Sep
- Market cap
- $48.6M
- P/E
- 0.0×
Follow DWTX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
4.49 | 2.76 | 5.86 | 3.89 |
Net Debt/EBITDA |
0.64 | 1.71 | 2.61 | 0.68 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.21 | 0.96 | 0.92 | 0.31 | |
Capex/Depreciation |
0.00 | 0.00 | — | — | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.87 | 0.90 | 0.84 | 0.86 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(1.71) | (0.73) | (0.14) | (0.11) | |
Cash per Share |
5.28 | 1.31 | 0.39 | 0.28 | |
Shareholders Equity per Share |
40.33 | 15.05 | 2.40 | 2.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
40.33 | 15.05 | 2.40 | 2.00 | |
Free Cash Flow |
(3.27) | (3.64) | (4.59) | (3.61) | |
Working Capital |
9.06 | 5.37 | 12.44 | 8.19 | |
Net Current Asset Value |
(2.95) | (6.84) | 0.42 | (1.10) | |
| Other line items | |||||
Quick Ratio |
3.90 | 2.13 | 5.17 | 3.39 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.71) | (0.73) | (0.14) | (0.11) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
0.52 | 1.00 | 0.65 | 0.45 | |
Average Assets |
47.14 | 92.24 | 96.10 | 88.59 | |
Average Common Equity |
(16.06) | 32.39 | 31.36 | 25.13 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates